Neurologic - Demyelinating Disease

Apr 2014

Guidance is compiled and interpreted by professional pilots and physicians at from the 2014 AME Guide, FAA and FDA web data ( &, instructions specified in the Aeronautical Information Manual, Federal Air Surgeon Bulletins from 1999-2015, and 14 CFR Part 61 and Part 67 (the FARs).

Decision Grid - Aerospace Medical Dispositions

FAA Aerospace Medical Disposition Grid for
Item 46. Neurologic - Demyelinating Disease





Acute Optic Neuritis;

Allergic Encephalomyelitis;

Landry Guillain Barre Syndrome;

Myasthenia Gravis; or

Multiple Sclerosis
All Submit all pertinent medical records, current neurologic report, to comment on involvement and persisting deficit, period of stability without symptoms, name and dosage of medication(s) and side effects Requires FAA Decision

17 Factors used in determining eligibility will include the medical history, neurological involvement and persisting deficit, period of stability without symptoms, type and dosage of medications used, and general health. A neurological and/or general medical consultation will be necessary in most instances.

This page discussed the Demyelinating Disease portion of the Neurologic section of the Fight Physical Examination required of pilots.

Reminder: use to familiarize yourself with aviation medical regulations and guidelines, but always discuss your specific situation with one or more AMEs before dedicating resources toward expensive clinical workups. Find an AME now